Market Cap

Panbela Therapeutics Inc. Market Capitalization:

$6.4 Million

USD as of Jan. 1, 2024

business Panbela Therapeutics Inc. Company Profile

Panbela Therapeutics Inc. Main Stock Listing

NASDAQ: PBLA

Market Capitalization History of Panbela Therapeutics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Panbela Therapeutics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $6.4 M 86.50%
Jan. 1, 2023 $3.5 M 35.68%
Jan. 1, 2022 $2.5 M -61.69%
Jan. 1, 2021 $6.6 M 6.92%
Jan. 1, 2020 $6.2 M 30.00%
Jan. 1, 2019 $4.8 M -51.34%
Jan. 1, 2018 $9.8 M -8.67%
Jan. 1, 2017 $10.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Panbela Therapeutics Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Panbela Therapeutics Inc. has the following listings and related stock indices.


Stock: NASDAQ: PBLA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.